23 May 2024 false No description of principal activity Taxfiler 2024.6 15736825business:PrivateLimitedCompanyLtd2024-05-232025-04-30 157368252024-05-22 157368252024-05-232025-04-30 15736825business:AuditExempt-NoAccountantsReport2024-05-232025-04-30 15736825business:FilletedAccounts2024-05-232025-04-30 157368252025-04-30 15736825business:Director12024-05-232025-04-30 15736825core:WithinOneYear2025-04-30 15736825core:ShareCapitalcore:PreviouslyStatedAmount2025-04-30 15736825core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-04-30 15736825core:PreviouslyStatedAmount2025-04-30 15736825business:SmallEntities2024-05-232025-04-30 15736825countries:EnglandWales2024-05-232025-04-30 15736825core:MotorVehicles2024-05-22 15736825core:MotorVehicles2024-05-232025-04-30 15736825core:MotorVehicles2025-04-30 iso4217:GBP xbrli:pure
Company Registration No. 15736825 (England and Wales)
OIRYSF MEDICA LTD Unaudited accounts for the period from 23 May 2024 to 30 April 2025
OIRYSF MEDICA LTD Unaudited accounts Contents
Page
- 2 -
OIRYSF MEDICA LTD Company Information for the period from 23 May 2024 to 30 April 2025
Director
Eiona Wynne Al-Helli
Company Number
15736825 (England and Wales)
- 3 -
OIRYSF MEDICA LTD Statement of financial position as at 30 April 2025
2025 
Notes
£ 
Fixed assets
Tangible assets
36,848 
Current assets
Cash at bank and in hand
21,403 
Creditors: amounts falling due within one year
(15,000)
Net current assets
6,403 
Net assets
43,251 
Capital and reserves
Called up share capital
1 
Profit and loss account
43,250 
Shareholders' funds
43,251 
For the period ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 23 June 2025 and were signed on its behalf by
Eiona Wynne Al-Helli Director Company Registration No. 15736825
- 4 -
OIRYSF MEDICA LTD Notes to the Accounts for the period from 23 May 2024 to 30 April 2025
1
Statutory information
OIRYSF MEDICA LTD is a private company, limited by shares, registered in England and Wales, registration number 15736825.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
4
Tangible fixed assets
Motor vehicles 
£ 
Cost or valuation
At cost 
At 23 May 2024
- 
Additions
46,060 
At 30 April 2025
46,060 
Depreciation
Charge for the period
9,212 
At 30 April 2025
9,212 
Net book value
At 30 April 2025
36,848 
5
Creditors: amounts falling due within one year
2025 
£ 
Loans from directors
15,000 
6
Average number of employees
During the period the average number of employees was 0.
- 5 -